First Manhattan’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,500
| Closed | -$22.5K | – | 1292 |
|
|
2024
Q1 | $22.5K | Hold |
1,500
| – | – | ﹤0.01% | 1016 |
|
|
2023
Q4 | $22.5K | Buy |
1,500
+500
| +50% | +$7.5K | ﹤0.01% | 1010 |
|
|
2023
Q3 | $14K | Hold |
1,000
| – | – | ﹤0.01% | 1078 |
|
|
2023
Q2 | $10.4K | Hold |
1,000
| – | – | ﹤0.01% | 1136 |
|
|
2023
Q1 | $9.24K | Hold |
1,000
| – | – | ﹤0.01% | 1223 |
|
|
2022
Q4 | $8.87K | Hold |
1,000
| – | – | ﹤0.01% | 1269 |
|
|
2022
Q3 | $8K | Hold |
1,000
| – | – | ﹤0.01% | 1248 |
|
|
2022
Q2 | $8K | Hold |
1,000
| – | – | ﹤0.01% | 1273 |
|
|
2022
Q1 | $8K | Hold |
1,000
| – | – | ﹤0.01% | 1323 |
|
|
2021
Q4 | $9K | Hold |
1,000
| – | – | ﹤0.01% | 1306 |
|
|
2021
Q3 | $16K | Hold |
1,000
| – | – | ﹤0.01% | 1200 |
|
|
2021
Q2 | $15K | Hold |
1,000
| – | – | ﹤0.01% | 1212 |
|
|
2021
Q1 | $19K | Hold |
1,000
| – | – | ﹤0.01% | 1141 |
|
|
2020
Q4 | $18K | Hold |
1,000
| – | – | ﹤0.01% | 1075 |
|
|
2020
Q3 | $19K | Hold |
1,000
| – | – | ﹤0.01% | 1034 |
|
|
2020
Q2 | $26K | Hold |
1,000
| – | – | ﹤0.01% | 988 |
|
|
2020
Q1 | $17K | Buy |
1,000
+500
| +100% | +$8.5K | ﹤0.01% | 1034 |
|
|
2019
Q4 | $16K | Hold |
500
| – | – | ﹤0.01% | 1087 |
|
|
2019
Q3 | $11K | Hold |
500
| – | – | ﹤0.01% | 1149 |
|
|
2019
Q2 | $17K | Buy |
+500
| New | +$17K | ﹤0.01% | 1110 |
|